We sat down with Dr. Eid at his New York City office to ask him about the latest developments in penile implant therapy.
Phase 3 studies assessing XIAFLEX show this agent may significantly improve quality of life.
Avanafil has demonstrated a higher selectivity against the inhibition of phosphodiesterase 11.
Penile traction therapy reduced curvature and significantly improved erectile function and hardness.
Range of risk factors identified for incidence and remission of ED, dyadic and solitary sexual desire.
Drug no better than placebo in preventing erectile dysfunction after radiotherapy for prostate cancer.
Men with high cholesterol and ED who used the drugs experienced a significant 3.2-point increase in IIEF score versus controls.
In a study of patients undergoing coronary procedures, the incidence of CIN was 2.7% alprostadl recipients versus 11.1% of controls.
Systematic review and meta-analysis show that use of the lipid-lowering agents can improve erectile function scores.
In a trial, more patients taking sildenfail citrate than placebo daily had functional erections at 24 months.
Complications other than urinary incontinence or erectile dysfunction occur frequently following treatment for PCa.
In men aged 44 years or less, total testosterone levels drop off significantly after 9 AM, study shows.
Patients with coronary artery disease are more likely to have ED if they have elevated uric acid levels.
If it lasts more than 48 hours, the T-shunt procedure with intracavernous tunneling usually fails, leaving men with erectile dysfunction.
As fasting plasma glucose levels and HbA1c values increased, so did the odds of ED.
ED sufferers with diabetes are 55% more likely be prescribed second-line therapies than non-diabetics, data show.
It is the first medication approved by the agency for treating this erectile problem.
Collagenase clostridium histolyticum (Xioflex) is first non-surgical treatment to get FDA approval